 |
PDBsum entry 4qhc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4qhc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
54:5657-5664
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis.
|
|
S.Hazra,
S.G.Kurz,
K.Wolff,
L.Nguyen,
R.A.Bonomo,
J.S.Blanchard.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Mycobacterium tuberculosis is intrinsically resistant to most β-lactam
antibiotics because of the constitutive expression of the blaC-encoded
β-lactamase. This enzyme has extremely high activity against penicillins and
cephalosporins, but weaker activity against carbapenems. The enzyme can be
inhibited by clavulanate, avibactam, and boronic acids. In this study, we
investigated the ability of 6-methylidene β-lactams to inhibit BlaC. One such
compound, penem 2, inhibited BlaC more than 70 times more efficiently than
clavulanate. The compound forms a covalent complex with BlaC as shown by mass
spectrometry. Crystallization of the complex revealed that the bound inhibitor
was covalently attached via the Ser70 active site residue and that the
covalently, acylated form of the inhibitor had undergone additional chemistry
yielding a 4,7-thiazepine ring in place of the β-lactam and a thiazapyroline
ring generated as a result of β-lactam ring opening. The stereochemistry of the
product of the 7-endo-trig cyclization was the opposite of that observed
previously for class A and D β-lactamases. Addition of penem 2 greatly
synergized the antibacterial properties of both ampicillin and meropenem against
a growing culture of M. tuberculosis. Strikingly, penem 2 alone showed
significant growth inhibition, suggesting that in addition to its capability of
efficiently inhibiting BlaC, it also inhibited the peptidoglycan cross-linking
transpeptidases.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |